What Veracyte Genomics AI does
Veracyte provides AI-powered genomic classifiers for thyroid, breast, and lung cancer that determine malignancy and predict treatment response from biopsy samples. Reduces unnecessary surgery for ambiguous diagnoses.
How Veracyte Genomics AI compares with its closest alternatives
1 of the 5 closest alternatives has a free plan; Veracyte Genomics AI does not. 4 of the 5 offer an API; FalcoScan's records show none for Veracyte Genomics AI. Veracyte Genomics AI offers a web app. Of the alternatives, all 5 offer a web app. Veracyte Genomics AI was founded in 2008; the alternatives were founded between 2016 and 2024. Veracyte Genomics AI is based in South San Francisco, United States; all the 4 alternatives with a known headquarters are in the United States too.